Intervention not reported
- Prophylactic antibiotics or G(M)‐CSF for the prevention of infections and improvement of survival in cancer patients… 2015 · Cochrane Headline outcomes onlyno estimate extracted1 study · 115 participantsLow
Continuous showed no clear difference in all‐cause mortality compared with intermittent Antibiotic Infusions (moderate certainty).
Monotherapy showed no clear difference in all‐cause mortality; compared with combination therapy (moderate certainty).
Carbapenems showed no clear difference in all‐cause mortality; compared with non‐carbapenems (moderate certainty).
It is very uncertain whether cefepime changes all‐cause mortality Maximum compared with ceftazidime (very low certainty).
The review found no eligible studies for this question.
Azithromycin showed no clear difference in all‐cause mortality at day 28 compared with placebo or standard of care alone (high certainty).
Azithromycin showed no clear difference in all‐cause mortality at day 28 compared with placebo or standard of care alone (low certainty).
The review found no eligible studies for this question.
The review found no eligible studies for this question.
The intervention showed no clear difference in secondary ‐ All‐cause mortality  (moderate certainty).